Haemonetics CorporationHAENYSE
Loading
Operating Income ScalingExpanding
Percentile Rank100
3Y CAGR+17.5%
5Y CAGR+23.1%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
+17.5%/yr
vs +16.9%/yr prior
5Y CAGR
+23.1%/yr
Recent deceleration
Acceleration
+0.6pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.8x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $253.26M | +14.2% |
| 2025 | $221.82M | +34.5% |
| 2024 | $164.88M | +5.7% |
| 2023 | $156.03M | +93.2% |
| 2022 | $80.75M | -10.0% |
| 2021 | $89.75M | -13.2% |
| 2020 | $103.35M | +23.7% |
| 2019 | $83.55M | +48.8% |
| 2018 | $56.16M | +389.8% |
| 2017 | $-19.38M | - |